We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$194M
Cap. Flow
+$40.5M
Cap. Flow %
2.24%
Top 10 Hldgs %
63.7%
Holding
392
New
24
Increased
176
Reduced
102
Closed
74

Top Buys

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$32.5M
2
AMAT icon
Applied Materials
AMAT
+$26.5M
3
AAPL icon
Apple
AAPL
+$13.7M
4
MSFT icon
Microsoft
MSFT
+$11.9M
5
NVDA icon
NVIDIA
NVDA
+$9.49M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$28.3M
2
BEKE icon
KE Holdings
BEKE
+$13.2M
3
TSM icon
TSMC
TSM
+$13.2M
4
ASX icon
ASE Group
ASX
+$7.59M
5
IQ icon
iQIYI
IQ
+$6.13M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.73%
2 Technology 31.74%
3 Communication Services 9.52%
4 Healthcare 5.08%
5 Financials 4.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNC icon
276
Centene
CNC
$32B
$219K 0.01%
3,309
+199
+6% +$14.5K
GS icon
277
Goldman Sachs
GS
$301B
$219K 0.01%
484
-9
-2% -$3.95K
DNLI icon
278
Denali Therapeutics
DNLI
$3.84B
$214K 0.01%
9,200
-11,352
-55% -$218K
DVAX
279
DELISTED
Dynavax Technologies
DVAX
$213K 0.01%
18,929
-14,051
-43% -$164K
MTD icon
280
Mettler-Toledo International
MTD
$28B
$211K 0.01%
151
-18
-11% -$24.6K
WST icon
281
West Pharmaceutical
WST
$23.7B
$209K 0.01%
634
+21
+3% +$7.42K
UNP icon
282
Union Pacific
UNP
$183B
$209K 0.01%
922
ZBH icon
283
Zimmer Biomet
ZBH
$19.2B
$208K 0.01%
1,917
+189
+11% +$22.3K
T icon
284
AT&T
T
$178B
$207K 0.01%
10,815
TDY icon
285
Teledyne Technologies
TDY
$28.8B
$206K 0.01%
+532
New +$211K
STE icon
286
Steris
STE
$22.8B
$206K 0.01%
939
+20
+2% +$4.34K
COP icon
287
ConocoPhillips
COP
$157B
$204K 0.01%
1,782
CAH icon
288
Cardinal Health
CAH
$54.6B
$202K 0.01%
2,054
+159
+8% +$16.2K
HOLX
289
DELISTED
Hologic
HOLX
$202K 0.01%
2,715
+66
+2% +$4.95K
RTX icon
290
RTX Corp
RTX
$285B
$201K 0.01%
+2,007
New +$208K
NVAX icon
291
Novavax
NVAX
$1.53B
$201K 0.01%
15,904
-63,610
-80% -$640K
AGIO icon
292
Agios Pharmaceuticals
AGIO
$1.99B
$201K 0.01%
4,668
-5,785
-55% -$209K
AXP icon
293
American Express
AXP
$225B
$200K 0.01%
+865
New +$200K
VTRS icon
294
Viatris
VTRS
$18.8B
$199K 0.01%
18,762
+2,275
+14% +$25.1K
ADMA icon
295
ADMA Biologics
ADMA
$2.09B
$190K 0.01%
16,998
-15,243
-47% -$128K
RXRX icon
296
Recursion Pharmaceuticals
RXRX
$1.79B
$181K 0.01%
24,165
-14,562
-38% -$127K
WBD icon
297
Warner Bros
WBD
$72.1B
$178K 0.01%
23,941
+538
+2% +$4.31K
BCRX icon
298
BioCryst Pharmaceuticals
BCRX
$2.51B
$175K 0.01%
28,285
-45,895
-62% -$253K
CPRX
299
DELISTED
Catalyst Pharmaceutical
CPRX
$175K 0.01%
11,266
-11,737
-51% -$183K
IBRX icon
300
ImmunityBio
IBRX
$8.53B
$167K 0.01%
26,458
-35,464
-57% -$234K

Similar funds

E Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, E Fund Management held 392 positions worth $1.81B, up 12% from $1.61B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

E Fund Management's Q2 2024 filing shows 24 new, 176 increased, 102 reduced and 74 closed positions. Its largest new stake was Futu Holdings: 480,000 shares worth $31.5M. The largest sale was Advanced Micro Devices, an estimated $28.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q2 2024 buy was Futu Holdings: 480,000 shares worth $31.5M.
  • E Fund Management added most to Applied Materials in Q2 2024, an estimated $26.5M increase.
  • E Fund Management's biggest Q2 2024 reduction was Advanced Micro Devices, cutting an estimated $28.3M.
  • E Fund Management fully exited Yum China in Q2 2024, selling an estimated $5.17M.
  • E Fund Management's ten largest holdings make up 64% of its $1.81B portfolio in Q2 2024.
  • E Fund Management opened 24 new positions and closed 74 in Q2 2024.
  • E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.81B.

Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.